Date, Kashmira https://orcid.org/0000-0001-6018-8314
Fowler, Kyle
Baniecki, Mary Lynn
Perez, Katherine K.
Toussi, Sima S.
Thomas, Elaine
Schneider, Katherine T.
Ruiz, Ornella
Seabroke, Suzie
Chatzikonstantinidou, Konstantina
Sarabia, Laura E.
Gessner, Bradford
Begier, Elizabeth
Funding for this research was provided by:
Pfizer
Article History
Received: 5 February 2026
Accepted: 21 April 2026
First Online: 7 May 2026
Declarations
:
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
: Ornella Ruiz, Suzie Seabroke, Konstantina Chatzikonstantinidou, and Laura E. Sarabia are employees of P95, which received funding from Pfizer Inc. in connection with this research and the development of this manuscript. Kashmira Date, Kyle Fowler, Mary Lynn Baniecki, Katherine K. Perez, Sima S. Toussi, Elaine Thomas, Katherine T. Schneider, and Elizabeth Begier are employees of Pfizer Inc. Bradford Gessner was affiliated with Pfizer Inc. while conducting this study and joined EpiVac Consulting during manuscript completion.